The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
110988653 11098865 3 F 201502 20160721 20150508 20160728 EXP BR-AMGEN-BRASP2015011845 AMGEN 53.00 YR A F Y 0.00000 20160728 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
110988653 11098865 1 PS ENBREL ETANERCEPT 1 Unknown 50MG, TWICE WEEKLY 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE BIW
110988653 11098865 2 SS ENBREL ETANERCEPT 1 Unknown 50MG, TWICE WEEKLY 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE BIW
110988653 11098865 3 C RIVOTRIL CLONAZEPAM 1 UNK 0
110988653 11098865 4 C RIVOTRIL CLONAZEPAM 1 UNK 0
110988653 11098865 5 C RIVOTRIL CLONAZEPAM 1 UNK 0
110988653 11098865 6 C RIVOTRIL CLONAZEPAM 1 UNK 0
110988653 11098865 7 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 UNK 0
110988653 11098865 8 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 UNK 0
110988653 11098865 9 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 UNK 0
110988653 11098865 10 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 UNK 0
110988653 11098865 11 C FUROSEMIDE. FUROSEMIDE 1 UNK 0
110988653 11098865 12 C FUROSEMIDE. FUROSEMIDE 1 0
110988653 11098865 13 C CAPTOPRIL. CAPTOPRIL 1 UNK 0
110988653 11098865 14 C DAIVOBET BETAMETHASONE DIPROPIONATECALCIPOTRIENE 1 UNK 0
110988653 11098865 15 C CLOBETAZOL CLOBETASOL PROPIONATE 1 UNK 0
110988653 11098865 16 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 25 MG, UNK 0 25 MG
110988653 11098865 17 C CEWIN ASCORBIC ACID 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
110988653 11098865 1 Psoriasis
110988653 11098865 3 Anxiety
110988653 11098865 4 Pain
110988653 11098865 5 Depression
110988653 11098865 6 Sedative therapy
110988653 11098865 7 Anxiety
110988653 11098865 8 Pain
110988653 11098865 9 Depression
110988653 11098865 10 Sedative therapy
110988653 11098865 11 Blood pressure measurement
110988653 11098865 12 Blood pressure measurement
110988653 11098865 13 Blood pressure abnormal
110988653 11098865 14 Skin disorder
110988653 11098865 15 Inflammation of wound

Outcome of event

Event ID CASEID OUTC COD
110988653 11098865 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
110988653 11098865 Condition aggravated
110988653 11098865 Psoriasis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
110988653 11098865 1 201501 201502 0
110988653 11098865 2 201503 0
110988653 11098865 3 2005 0
110988653 11098865 7 2005 0
110988653 11098865 9 2005 0
110988653 11098865 11 2005 0
110988653 11098865 13 2005 0
110988653 11098865 14 2012 0